Human Epidermal Growth Factor Receptor 2 Pan Tumor Indication for Trastuzumab Deruxtecan

Jan Trøst Jørgensen^*, Kristian Egebjerg, Anne-Vibeke Lænkholm, Morten Mau-Sørensen

^*Corresponding author af dette arbejde

Originalsprog	Engelsk
Artikelnummer	e24.00884
Tidsskrift	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Sider (fra-til)	JCO2400884
ISSN	0732-183X
DOI	https://doi.org/10.1200/JCO.24.00884
Status	E-pub ahead of print - 5 aug. 2024

Adgang til dokumentet

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

@article{5fed5fc2a3a7441aa1f69d5a30890a86,

title = "Human Epidermal Growth Factor Receptor 2 Pan Tumor Indication for Trastuzumab Deruxtecan",

author = "J{\o}rgensen, {Jan Tr{\o}st} and Kristian Egebjerg and Anne-Vibeke L{\ae}nkholm and Morten Mau-S{\o}rensen",

year = "2024",

month = aug,

day = "5",

doi = "10.1200/JCO.24.00884",

language = "English",

pages = "JCO2400884",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Human Epidermal Growth Factor Receptor 2 Pan Tumor Indication for Trastuzumab Deruxtecan

AU - Jørgensen, Jan Trøst

AU - Egebjerg, Kristian

AU - Lænkholm, Anne-Vibeke

AU - Mau-Sørensen, Morten

PY - 2024/8/5

Y1 - 2024/8/5

UR - http://www.scopus.com/inward/record.url?scp=85200890381&partnerID=8YFLogxK

U2 - 10.1200/JCO.24.00884

DO - 10.1200/JCO.24.00884

M3 - Comment/debate

C2 - 39102639

SN - 0732-183X

SP - JCO2400884

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

M1 - e24.00884

ER -